肾癌-话题@MedSci

#肾癌#

11篇内容 | 3840人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1239853, encodeId=b5fd1239853eb, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=手术是肾癌治疗的首选手段！早期、中期、晚期肾癌患者均可获益, objectType=article, longId=735038, objectId=2cdde3503837, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220806/1659762712879_8252897.webp, objectUrl=/article/show_article.do?id=2cdde3503837, replyNumber=0, likeNumber=158, createdTime=2022-08-20, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cdde3503837, moduleTitle=手术是肾癌治疗的首选手段！早期、中期、晚期肾癌患者均可获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cdde3503837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214273, encodeId=5bdc12142e3a9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=肾癌基因检测中国专家共识（2021版）, objectType=guider, longId=16736, objectId=3d0911c002a09e6b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=3d0911c002a09e6b, replyNumber=0, likeNumber=185, createdTime=2022-04-25, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d0911c002a09e6b, moduleTitle=肾癌基因检测中国专家共识（2021版）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=3d0911c002a09e6b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214272, encodeId=069a12142e2c9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=2021 CSCO 肾癌诊疗指南, objectType=guider, longId=15569, objectId=42ac51c002293082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=42ac51c002293082, replyNumber=0, likeNumber=185, createdTime=2022-04-25, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42ac51c002293082, moduleTitle=2021 CSCO 肾癌诊疗指南, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=42ac51c002293082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1071675, encodeId=4c5d10e1675b9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=抗肿瘤药物处方审核专家共识：肾癌, objectType=guider, longId=14028, objectId=32e601c002138947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=32e601c002138947, replyNumber=0, likeNumber=190, createdTime=2021-11-19, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32e601c002138947, moduleTitle=抗肿瘤药物处方审核专家共识：肾癌, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=32e601c002138947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=922521, encodeId=853c92252114, content=<a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a>单药一线治疗晚期非透明细胞<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=JCO：帕博利珠单抗单药一线治疗晚期非透明细胞肾癌的客观缓解率可达26.7％, objectType=article, longId=206735, objectId=bdea206e35cc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/syringe-injection-by-doctor-PG5KHML.jpg, objectUrl=/article/show_article.do?id=bdea206e35cc, replyNumber=0, likeNumber=252, createdTime=2021-02-03, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdea206e35cc, moduleTitle=JCO：帕博利珠单抗单药一线治疗晚期非透明细胞肾癌的客观缓解率可达26.7％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdea206e35cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916395, encodeId=098b91639510, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, objectType=article, longId=205718, objectId=9075205e18ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610258817277_5295905.jpg, objectUrl=/article/show_article.do?id=9075205e18ad, replyNumber=0, likeNumber=303, createdTime=2021-01-14, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9075205e18ad, moduleTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9075205e18ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916383, encodeId=44df916383e9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a><a href='/topic/show?id=3ad9818917c' target=_blank style='color:#2F92EE;'>#肥胖#</a>, objectTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, objectType=article, longId=205718, objectId=9075205e18ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610258817277_5295905.jpg, objectUrl=/article/show_article.do?id=9075205e18ad, replyNumber=0, likeNumber=294, createdTime=2021-01-13, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9075205e18ad, moduleTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9075205e18ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=915874, encodeId=a0a59158e47d, content=<a href='/topic/show?id=fffe10411443' target=_blank style='color:#2F92EE;'>#阿昔替尼联合派姆单抗#</a>＆<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, objectType=article, longId=205645, objectId=b54a2056457f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021111/1610374641055_2110107.JPG, objectUrl=/article/show_article.do?id=b54a2056457f, replyNumber=0, likeNumber=220, createdTime=2021-01-12, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b54a2056457f, moduleTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b54a2056457f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肾癌

2020-05-29

小小医者 (审核中...)

前往app查看评论内容

#肾癌#

手术是肾癌治疗的首选手段！早期、中期、晚期肾癌患者均可获益

2022-08-20

病毒猎手 (审核中...)

前往app查看评论内容

#肾癌#

肾癌基因检测中国专家共识（2021版）

2022-04-25

病毒猎手 (审核中...)

前往app查看评论内容

#肾癌#

2021 CSCO 肾癌诊疗指南

2022-04-25

病毒猎手 (审核中...)

前往app查看评论内容

#肾癌#

抗肿瘤药物处方审核专家共识：肾癌

2021-11-19

lovetcm (审核中...)

前往app查看评论内容

#帕博利珠单抗#单药一线治疗晚期非透明细胞#肾癌#

JCO：帕博利珠单抗单药一线治疗晚期非透明细胞肾癌的客观缓解率可达26.7％

2021-02-03

zb1235672 (审核中...)

前往app查看评论内容

#肾癌#

J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效

2021-01-14

Nebula-Qin (审核中...)

前往app查看评论内容

#肾癌##肥胖#

J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效

2021-01-13

zb1235672 (审核中...)

前往app查看评论内容

#阿昔替尼联合派姆单抗#＆#肾癌#

Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！

2021-01-12

科室
- - 订阅+
  - 更多科室
工具
服务